via 340B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give discounts on 340B drugs at the point of sale.
via Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial on a clinical hold, the company announced Feb. 4.
via Medtronic has recalled systems for draining fluid from the brain because of the risk of cracks and leaks, the Food and Drug Administration said Monday.